Angus Completes Divestiture From Dow

Investment funds managed by Golden Gate Capital acquired Angus Chemical Company from The Dow Chemical Company. Angus will continue to be led by its current senior management team, including President and CEO Mark A. Henning. Additionally, ANGUS will continue to honor all customer, licensing and supplier contracts and related agreements, according to the company.

The $1.215 billion transaction includes the Angus business headquarters and R&D facility in Buffalo Grove, IL; manufacturing facilities located in Sterlington, LA, and Ibbenbueren, Germany; a life-science additive facility in Niagara Falls, NY; as well as the associated business, inventory, customer contracts, process technology, business know-how and certain intellectual property.

For more information, visit: www.angus.com